These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10788453)

  • 21. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
    Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive oxygen species-mediated homologous downregulation of angiotensin II type 1 receptor mRNA by angiotensin II.
    Ichiki T; Takeda K; Tokunou T; Funakoshi Y; Ito K; Iino N; Takeshita A
    Hypertension; 2001 Feb; 37(2 Pt 2):535-40. PubMed ID: 11230331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases.
    Touyz RM; Deng LY; He G; Wu XH; Schiffrin EL
    J Hypertens; 1999 Jul; 17(7):907-16. PubMed ID: 10419063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
    Seta K; Sadoshima J
    J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression.
    Takeda K; Ichiki T; Tokunou T; Iino N; Fujii S; Kitabatake A; Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):868-73. PubMed ID: 11348889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide inhibits angiotensin II-induced activation of the calcium-sensitive tyrosine kinase proline-rich tyrosine kinase 2 without affecting epidermal growth factor receptor transactivation.
    Wang D; Yu X; Brecher P
    J Biol Chem; 1999 Aug; 274(34):24342-8. PubMed ID: 10446212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
    Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
    Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase.
    Murasawa S; Matsubara H; Mori Y; Masaki H; Tsutsumi Y; Shibasaki Y; Kitabayashi I; Tanaka Y; Fujiyama S; Koyama Y; Fujiyama A; Iba S; Iwasaka T
    J Biol Chem; 2000 Sep; 275(35):26856-63. PubMed ID: 10856308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
    Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
    Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
    Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
    Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells.
    Lu G; Meier KE; Jaffa AA; Rosenzweig SA; Egan BM
    Hypertension; 1998 Apr; 31(4):978-85. PubMed ID: 9535424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II activates pp60c-src in vascular smooth muscle cells.
    Ishida M; Marrero MB; Schieffer B; Ishida T; Bernstein KE; Berk BC
    Circ Res; 1995 Dec; 77(6):1053-9. PubMed ID: 7586216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II receptor coupling to phospholipase D is mediated by the betagamma subunits of heterotrimeric G proteins in vascular smooth muscle cells.
    Ushio-Fukai M; Alexander RW; Akers M; Lyons PR; Lassègue B; Griendling KK
    Mol Pharmacol; 1999 Jan; 55(1):142-9. PubMed ID: 9882708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II.
    Hattori Y; Akimoto K; Kasai K
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1144-9. PubMed ID: 10891386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.
    Ushio-Fukai M; Griendling KK; Becker PL; Hilenski L; Halleran S; Alexander RW
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):489-95. PubMed ID: 11304462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.
    Eguchi S; Iwasaki H; Ueno H; Frank GD; Motley ED; Eguchi K; Marumo F; Hirata Y; Inagami T
    J Biol Chem; 1999 Dec; 274(52):36843-51. PubMed ID: 10601235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
    Shibasaki Y; Matsubara H; Nozawa Y; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Hypertension; 2001 Sep; 38(3):367-72. PubMed ID: 11566906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators.
    Seshiah PN; Weber DS; Rocic P; Valppu L; Taniyama Y; Griendling KK
    Circ Res; 2002 Sep; 91(5):406-13. PubMed ID: 12215489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.